Pharmore Legal and Compliance

Wishing all our relations happy holidays and a healthy 2025. We will continue to provide our legal and compliance consulting and interim management opportunities in the year to come.

The European Commission has made commitments offered by Vifor legally binding under EU antitrust rules. The commitments address the Commission's competition concerns relating to Vifor's potential disparagement of Monofer, the closest - and potentially only – competitor of Vifor's flagship intravenous iron medicine in Europe, Ferinject. https://lnkd.in/e-tx79QJ

What is the new EU commission up to that is relevant to life-sciences. Putting research and innovation at the heart of our economy • Increase our research spending to focus more on strategic priorities. • Expand the European Research Council and the European Innovation Council. • New European Biotech Act in 2025. This will be part of a broader Strategy for European Life Sciences to look at how we can support our green and digital transitions and develop high-value technologies. • Also develop ideas through new public-private partnerships, such as joint undertakings. From the Political Guidelines 2024-2029 by Ursula von der Leyen

Thanks Co-Pilot Mr. Nico Jansen, MBA, DipM, MCIM (LLM), has an impressive background. He studied law at the University of Utrecht, the Netherlands; business administration at Edinburgh Business School at Heriot-Watt University in Scotland; and marketing at the Netherlands Institute for Marketing (NIMA) and the British Chartered Institute of Marketing (CIM). He has held international sales, marketing, and legal roles in healthcare and publishing. In recent years, he combined entrepreneurial activities with teaching positions at the Faculty of Economics and Business of the Vrije Universiteit and Inholland University of Applied Sciences, both in Amsterdam, the Netherlands. As an author, he has focused on the relationship between law and business, combining business and legal theories into a concise practical overview with an emphasis on strategy development and implementation within companies. Contact n.jansen@lawandselfregulation.com

Thanks Co-Pilot Mr. Nico Jansen, MBA, DipM, MCIM (LLM), heeft een indrukwekkende achtergrond. Hij studeerde rechten aan de Rijksuniversiteit in Utrecht, Nederland; bedrijfskunde aan de Edinburgh Business School van Heriot-Watt University in Schotland; en marketing aan het Nederlands Instituut voor Marketing (NIMA) en het Britse Chartered Institute of Marketing (CIM). Hij heeft internationale verkoop-, marketing- en juridische functies bekleed in de gezondheidszorg en uitgeverijsector. Tot voor kort combineerde hij ondernemersactiviteiten met docentschappen aan de faculteit Economie en Bedrijfskunde van de Vrije Universiteit en Inholland University of Applied Sciences, beiden in Amsterdam, Nederland. Als auteur heeft hij zich gericht op het verband tussen recht en bedrijfsleven, waarbij hij zakelijke en juridische theorieën combineert tot een beknopt praktisch overzicht met nadruk op strategieontwikkeling en implementatie binnen bedrijven. Je kunt contact met hem opnemen via n.jansen@lawandselfregulation.com.

Beware: the WHO prepares an attack on the legal (IPR) protection of health products. See: Article-by-Article Compilation of Proposed Amendments to the International Health Regulations (2005) submitted in accordance with decision WHA75(9) (2022) New Article 13A: Access to Health Products, Technologies and Know-How for Public Health Response 3. States Parties shall provide, in their intellectual property laws and related laws and regulations, exemptions and limitations to the exclusive rights of intellectual property holders to facilitate the manufacture, export and import of the required health products, including their materials and components.